These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4019705)

  • 1. Determining the duration of comparative clinical trials while allowing for cure.
    Sposto R; Sather HN
    J Chronic Dis; 1985; 38(8):683-90. PubMed ID: 4019705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of accrual and follow-up for two-stage clinical trials.
    Case LD; Morgan TM
    Lifetime Data Anal; 2001 Mar; 7(1):21-37. PubMed ID: 11280845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planning the size of survival time clinical trials with allowance for stratification.
    Moussa MA
    Stat Med; 1988 May; 7(5):559-69. PubMed ID: 3387715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonparametric estimation of duration of accrual and total study length for clinical trials.
    Morgan TM
    Biometrics; 1987 Dec; 43(4):903-12. PubMed ID: 3427175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size determination in clinical trials with an emphasis on exponentially distributed responses.
    Gross AJ; Hunt HH; Cantor AB; Clark BC
    Biometrics; 1987 Dec; 43(4):875-83. PubMed ID: 3427172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of duration of response in oncology trials.
    Ellis S; Carroll KJ; Pemberton K
    Contemp Clin Trials; 2008 Jul; 29(4):456-65. PubMed ID: 18187370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical controls, data banks, and randomized trials in clinical research: a review.
    Fleming TR
    Cancer Treat Rep; 1982 May; 66(5):1101-5. PubMed ID: 7083214
    [No Abstract]   [Full Text] [Related]  

  • 9. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.
    Gajewski BJ; Berry SM; Quintana M; Pasnoor M; Dimachkie M; Herbelin L; Barohn R
    Stat Med; 2015 Mar; 34(7):1134-49. PubMed ID: 25640114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A treatment allocation procedure for sequential clinical trials.
    Begg CB; Iglewicz B
    Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "constant intake rate" assumption in interim recruitment goal methodology for multicenter clinical trials.
    Williford WO; Bingham SF; Weiss DG; Collins JF; Rains KT; Krol WF
    J Chronic Dis; 1987; 40(4):297-307. PubMed ID: 3558706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trials and research strategy.
    Simon R
    Cancer Treat Rep; 1982 May; 66(5):1083-7. PubMed ID: 7083212
    [No Abstract]   [Full Text] [Related]  

  • 13. A generalized estimating equation approach for modeling random length binary vector data.
    Albert PS; Follmann DA; Barnhart HX
    Biometrics; 1997 Sep; 53(3):1116-24. PubMed ID: 9290230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extension of the proportional-hazards model for grouped data.
    Aranda-Ordaz FJ
    Biometrics; 1983 Mar; 39(1):109-17. PubMed ID: 6871339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring event times in early phase clinical trials: some practical issues.
    Thall PF; Wooten LH; Tannir NM
    Clin Trials; 2005; 2(6):467-78. PubMed ID: 16422307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group.
    Wilson JF; Jenkin RD; Anderson JR; Chilcote RR; Coccia P; Exelby PR; Kersey J; Kjeldsberg CR; Kushner J; Meadows A
    Cancer; 1984 Apr; 53(8):1695-704. PubMed ID: 6697306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A random walk model for evaluating clinical trials involving serial observations.
    Hopper JL; Young GP
    Stat Med; 1988 May; 7(5):581-90. PubMed ID: 3387717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trials: design and analysis.
    Green SB
    Semin Oncol; 1981 Dec; 8(4):417-23. PubMed ID: 7323813
    [No Abstract]   [Full Text] [Related]  

  • 19. Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias.
    Pritchett EL; Lee KL
    J Clin Epidemiol; 1988; 41(9):851-8. PubMed ID: 3183691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.
    Zhang X; Long Q
    Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.